List of works by Lennart Minthon

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

scientific article published on September 2010

1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France

article

A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease

scientific article

A Quick Test for Cognitive Speed: a measure of cognitive speed in dementia with Lewy bodies.

scientific article published in August 2007

A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease

scientific article

A longitudinal study of physical function in patients with early-onset dementia

scientific article published on January 2012

A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy

scientific article published on 20 March 2013

A new automated method for analysis of rCBF-SPECT images based on the active-shape algorithm: normal values

scientific article

A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease

scientific article published on 25 May 2012

A novel ARC polymorphism is associated with reduced risk of Alzheimer's disease

scholarly article by Petronella Kettunen et al published July 2010 in Alzheimer's and Dementia

A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.

scientific article published in January 2013

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders

scientific article published in November 2012

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

scientific article

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease

scientific article

Altered CSF orexin and α-synuclein levels in dementia patients

scientific article

Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters

scientific article published on 9 October 2012

Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease

scientific article published in January 2012

An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease

scientific article published on 22 December 2014

Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment

scientific article

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

scientific article published in October 2014

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease

scientific article published on 29 January 2018

Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms

scientific article published on 14 January 2014

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

scientific article published on March 2006

Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent

scientific article published on 23 August 2010

Association of complement factor H Y402H gene polymorphism with Alzheimer's disease

scientific article published in September 2008

Association of the RAGE G82S polymorphism with Alzheimer's disease

scientific article

Associations between AQT processing speed and neuropsychological tests in neuropsychiatric patients.

scientific article published in June 2007

Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study

scientific article

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease

scientific article (publication date: 30 December 2010)

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

scientific article

Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.

scientific article published on 14 September 2012

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

scientific article published on 17 June 2011

Both total and phosphorylated tau are increased in Alzheimer's disease

scientific article published on May 2001

C4b-binding protein in Alzheimer's disease: Binding to Aβ1–42 and to dead cells

scientific article published on 16 June 2008

CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease

scientific article published on 30 January 2012

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

scientific article published on January 2016

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

scientific article published on 8 January 2008

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.

scientific article published on 3 November 2010

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

scientific article published in July 2009

CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly

scientific article published on 7 May 2012

CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival

scientific article published on 2 January 2006

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.

scientific article published on 19 February 2013

CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.

scientific article

CSF biomarkers predict a more malignant outcome in Alzheimer disease.

scientific article published in May 2010

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

scientific article published on 01 January 2000

Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?

scientific article published in June 2009

Cerebral Microbleeds and White Matter Hyperintensities in Cognitively Healthy Elderly: A Cross-Sectional Cohort Study Evaluating the Effect of Arterial Stiffness

scientific article published on 20 May 2015

Cerebral pattern of pro- and anti-inflammatory cytokines in dementias

scientific article

Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET

scientific article published on 9 February 2016

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates

scientific article published on 28 September 2011

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

scientific article published in June 1999

Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses

scientific article published in March 2010

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

scientific article published on 2 July 2007

Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients

scientific article

Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.

scientific article

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

article

Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia

scientific article

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

scientific article published in December 2014

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

scientific article published on January 2012

Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease

scientific article published on 18 February 2012

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

scientific article published on 01 September 1999

Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders

scientific article

Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.

scientific article published in April 2010

Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.

scientific article published on 21 October 2009

Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease.

scientific article published on 4 March 2011

Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.

scientific article published on 29 September 2010

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study

scientific article

Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil

scientific article

Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment.

scientific article published in August 2006

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

scientific article published on July 2015

Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death

scientific article

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

scientific article

Clinical utility of color-form naming in Alzheimer's disease: preliminary evidence.

scientific article published in December 2004

Cognitive impairment is undetected in medical inpatients: a study of mortality and recognition amongst healthcare professionals

scientific article

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

scientific article published on 23 July 2007

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study

scientific article (publication date: 2012)

Complement gene single nucleotide polymorphisms and biomarker endophenotypes of Alzheimer's disease

scientific article published in January 2013

Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease

scientific article

Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease

scientific article published on 12 August 2009

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

scientific article

Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease

scientific article

Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia

scientific article published in January 1996

Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

scientific article published in February 2010

Cortical blood flow during head-up postural change in subjects with orthostatic hypotension

scientific article published in October 1993

Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease

scientific article published on 6 June 2008

Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls

scholarly article by Johan Sundelöf et al published 11 August 2010 in Journal of Alzheimer's Disease

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

scientific article published on 01 May 2000

Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease

scientific article published in September 2001

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease

scientific article

Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden

scientific article

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

scientific article

Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study.

scientific article

Diabetes mellitus and elevated copeptin levels in middle age predict low cognitive speed after long-term follow-up

scientific article published on 29 January 2013

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

scientific article

Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health

scientific article published in January 2013

Differences in survival between patients with dementia with Lewy bodies and patients with Alzheimer's disease--measured from a fixed cognitive level

scientific article published in January 2011

Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease

scientific article

Disease progression and costs of care in Alzheimer's disease patients treated with donepezil: a longitudinal naturalistic cohort

scientific article published on 6 August 2011

Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.

scientific article published on 18 December 2006

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

scientific article published in April 2006

Effects of Alzheimer's peptide and α1-antichymotrypsin on astrocyte gene expression

article

Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment

scientific article

Electroencephalogram variability in dementia with lewy bodies, Alzheimer's disease and controls.

scientific article published on 8 October 2008

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease

scientific article

Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.

scientific article published on 5 November 2008

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

scientific article

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

scholarly article by Joakim Hertze et al published 10 September 2010 in Journal of Alzheimer's Disease

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

scientific article

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

scientific article published on 01 March 2001

Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease

scientific article

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

scientific article

Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders

scientific article published on 9 July 2013

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment

scientific article

Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy

scientific article published on 21 June 2004

Functional mannose-binding lectin haplotype variants are associated with Alzheimer's disease

scientific article published in January 2013

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort

scientific article

Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting

scientific article

Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia

scientific article published on March 2012

Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.

scientific article published on 29 September 2005

Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function

scientific article published in January 2015

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers

scientific article published on 28 February 2017

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism

scientific article

Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls

scholarly article by Johan Sundelöf et al published 7 January 2011 in Journal of Alzheimer's Disease

Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

scientific article

Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid

scientific article

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

scientific article

Importance and added value of functional impairment to predict mortality: a cohort study in Swedish medical inpatients

scientific article published on 30 May 2017

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis

scientific article published on 7 March 2016

Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia

article

Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia

scientific article published in January 2014

Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease

scientific article

Injury markers predict time to dementia in subjects with MCI and amyloid pathology

scientific article

Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease

scientific article published on 01 August 2007

Kinesin light chain 1 gene haplotypes in three conformational diseases.

scientific article published on 13 November 2009

Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies

scientific article

Lack of orthostatic symptoms in dementia patients with orthostatic hypotension

scientific article published on 18 April 2014

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease

scientific article

Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment ⬇️

scientific article published on January 1, 2011

Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease

scientific article published on 01 September 1995

Long-term rivastigmine treatment in a routine clinical setting

scientific article published on 26 August 2008

Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services

scientific article published on 4 September 2015

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study

scientific article published on 09 October 2015

Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease.

scientific article published in January 2012

Longitudinal stability of CSF biomarkers in Alzheimer's disease.

scientific article published on 6 April 2007

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease

scientific article published on 17 July 2009

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy

scientific article

Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients

scientific article published on 3 June 2010

Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies

scientific article published in January 2014

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

scientific article published in September 2003

Measurement of apolipoprotein E (apoE) in cerebrospinal fluid

scientific article published on 01 April 2000

Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment

scientific article

Medial temporal lobe atrophy increases the specificity of cerebrospinal fluid biomarkers in Alzheimer disease with minor cerebrovascular changes

scientific article published in July 2009

Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients

scientific article published on 16 June 2015

Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.

scientific article published on 5 May 2008

Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.

scientific article published in January 2013

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy

scientific article published on 17 February 2016

Modern dementia care on the rise thanks to national guidelines

scientific article published in November 2013

Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment

scientific article published on 10 May 2012

Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study

scientific article published on 26 September 2013

Multiple rapid automatic naming measures of cognition: normal performance and effects of aging.

scientific article published in June 2004

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease

scientific article published on 15 April 2016

NG2 cells, a new trail for Alzheimer's disease mechanisms?

scientific article

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.

scientific article published on 25 September 2010

Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration

scientific article published in January 1990

Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration.

scientific article

No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

scholarly article by Kaj Blennow et al published 11 August 2000 in Journal of Neural Transmission

No association of LOXL1 gene polymorphisms with Alzheimer's disease.

scientific article published on 11 May 2011

No association of VEGF polymorphims with Alzheimer's disease.

scientific article published on 20 October 2009

No diagnostic value of plasma clusterin in Alzheimer's disease

scientific article

No independent association between pulse wave velocity and dementia: a population-based, prospective study

scientific article published on 12 July 2017

Nonlinear association between pulse wave velocity and cognitive function: a population-based study

scientific article published in November 2014

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment

scientific article

Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.

scientific article published on 12 January 2010

Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG.

scientific article published in January 1993

Parietal lobe activation in rapid, automatized naming by adults

scientific article published on June 2002

Patients with Lewy body dementia use more resources than those with Alzheimer's disease

scientific article published on August 2007

Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease.

scientific article published in April 2007

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

scientific article published on 11 September 2015

Performance of middle-aged and elderly European minority and majority populations on a Cross-Cultural Neuropsychological Test Battery (CNTB).

scientific article published on 24 January 2018

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.

scientific article published on 29 August 2007

Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.

scientific article published in October 2000

Plasma tau levels in Alzheimer's disease

scientific article published on 28 March 2013

Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests

scientific article

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations

scientific article published on 23 October 2017

Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting

scientific article

Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State Index

scientific article published on January 2015

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.

scientific article published on 27 February 2013

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides

scientific article

Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment

scientific article published on 2 November 2010

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

scientific article published on 19 March 2007

Predictors of long-term cognitive outcome in Alzheimer's disease

scientific article published on 20 July 2011

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

scientific article published on 10 June 2009

Prevalence of Dementia With Lewy Body Symptoms: A Cross-Sectional Study in 40 Swedish Nursing Homes

scientific article published on 7 May 2016

Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

scientific article

Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies

scientific article published on 07 October 2013

Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia

scientific article published on 25 November 2011

Redistribution of blood flow in the cerebral cortex of normal subjects during head-up postural change

scientific article published in April 1992

Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.

scientific article published on 31 August 2016

Regional cerebral blood flow in Alzheimer's disease: classification and analysis of heterogeneity

scientific article published on 20 January 2004

Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients

scientific article

Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease

scientific article

Response to the Letter From Abid Iraqi, MD, CMD and Terry Hughes, RN, CS.

scientific article published in January 2017

Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.

scientific article

Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up

scientific article published on 3 July 2014

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease

scientific article

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

scientific article

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

scientific article published in October 1999

Sex-specific genetic predictors of Alzheimer's disease biomarkers

scientific article published on 02 July 2018

Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.

scientific article published on 6 May 2018

Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study

scientific article published on 3 May 2013

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years

article

Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services

scientific article

Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment

scientific article

Soluble adhesion molecules and angiotensin-converting enzyme in dementia

scientific article

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

scientific article

Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia

scientific article published in July 1997

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma

scientific article

TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.

scientific article published in June 2000

Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype

scientific article published in January 2001

Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients

scientific article published on 01 November 2001

Tacrine treatment modifies cerebrospinal fluid neuropeptide levels in Alzheimer's disease.

scientific article published in November 1994

Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's disease

scientific article

Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.

scientific article published on 20 January 2012

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies

scientific article published on 13 August 2015

The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort

scientific article published on July 2017

The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association

scientific article published on 11 September 2007

The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease

scientific article published in April 1997

The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study

scientific article published in January 2013

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

scientific article published on 8 April 2014

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia

scientific article published in January 2011

The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia

scientific article published on October 2010

The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia

scientific article

The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies

scientific article published on 01 February 2008

The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease.

scientific article published on 24 September 2009

The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease

scientific journal article

The transcobalamin 776C > G polymorphism may be a modifiable genetic risk factor for Alzheimer's disease

scientific article published on 01 June 2005

The usefulness of cube copying for evaluating treatment of Alzheimer's disease.

scientific article published in October 2008

There is a strong evidence that professional boxing results in chronic brain damage. The more head punches during a boxer's career, the bigger is the risk

scientific article

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls

scientific article published on 15 March 2014

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study

scientific article

Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease

scientific article

Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts ⬇️

scientific article

Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

article by David A Wolk et al published 1 September 2018 in JAMA Neurology

Usefulness of computed tomography linear measurements in diagnosing Alzheimer's disease.

scientific article published in February 2008

Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.

scientific article published in August 2006

White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study

scientific article published on 18 June 2009

[About mice and men. Not certain that findings in mice with Alzheimer disease can be applied in clinical reality]

scientific article published on 01 December 2006

[New discoveries on Alzheimer disease: new biochemical markers can hopefully improve diagnosis]

scientific article published in January 2000

α-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies

scholarly article by Clive Ballard et al published 14 September 2009 in International Psychogeriatrics

Paulina is supported by:

About Paulina

Help